Real-world outcomes in patients with unresected stage III non-small cell lung cancer View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-03

AUTHORS

Kellie J. Ryan, Karen E. Skinner, Ancilla W. Fernandes, Rajeshwari S. Punekar, Melissa Pavilack, Mark S. Walker, Noam A. VanderWalde

ABSTRACT

This study examined real-world clinical outcomes such as progression-free survival (PFS), time to metastasis (TTM), overall survival (OS), and health-related quality of life (HRQOL) in patients with unresected stage III non-small cell lung cancer (NSCLC) treated in the community setting. A retrospective review of medical records extracted from 10 US community oncology practices was conducted. Eligible patients were adults diagnosed with stage III NSCLC from 1/1/2011 to 3/1/2016 without evidence of surgical resection within 6 months after stage III NSCLC diagnosis (index date). PFS, OS, and TTM were assessed from the index date, and were analyzed using Kaplan-Meier and Cox regression analyses. HRQOL was assessed for a subset of patients using a patient-reported measure, the 86-item Patient Care Monitor (PCM). Linear mixed models (LMM) were used to assess the impact of patient characteristics and change in PCM scores associated with progression. Among the sample of 478 patients, median PFS (95% confidence interval) was 10 months (9-11), median OS was 20 months (17-22), and median TTM was 30 months (23-45). Most patients (58.2%) experienced disease progression, which the LMM showed to be associated with significant worsening of physical symptoms and psychological states (p < 0.001). This study documented PFS and OS consistent with published literature. The majority of patients experienced disease progression, which was associated with worsening of HRQOL. These findings highlighted the need for better therapeutic options in patients with unresected stage III NSCLC with potential to improve patient outcomes and HRQOL. More... »

PAGES

24

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12032-019-1249-1

DOI

http://dx.doi.org/10.1007/s12032-019-1249-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1111831523

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30706218


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "AstraZeneca (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418152.b", 
          "name": [
            "AstraZeneca, One MedImmune Way, 20878, Gaithersburg, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ryan", 
        "givenName": "Kellie J.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Vector Oncology (United States)", 
          "id": "https://www.grid.ac/institutes/grid.476107.3", 
          "name": [
            "Vector Oncology, 6555 Quince, Suite 400, 38119, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Skinner", 
        "givenName": "Karen E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418152.b", 
          "name": [
            "AstraZeneca, One MedImmune Way, 20878, Gaithersburg, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fernandes", 
        "givenName": "Ancilla W.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Sanofi (United States)", 
          "id": "https://www.grid.ac/institutes/grid.417555.7", 
          "name": [
            "Vector Oncology, 6555 Quince, Suite 400, 38119, Memphis, TN, USA", 
            "Sanofi, 50 Binney Street, 2nd floor, 02142, Cambridge, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Punekar", 
        "givenName": "Rajeshwari S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418152.b", 
          "name": [
            "AstraZeneca, One MedImmune Way, 20878, Gaithersburg, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pavilack", 
        "givenName": "Melissa", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Vector Oncology (United States)", 
          "id": "https://www.grid.ac/institutes/grid.476107.3", 
          "name": [
            "Vector Oncology, 6555 Quince, Suite 400, 38119, Memphis, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Walker", 
        "givenName": "Mark S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "West Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.488536.4", 
          "name": [
            "West Cancer Center, 7945 Wolf River Boulevard, 38138, Germantown, TN, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "VanderWalde", 
        "givenName": "Noam A.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1477-7525-9-46", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004761947", 
          "https://doi.org/10.1186/1477-7525-9-46"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-014-2892-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007214743", 
          "https://doi.org/10.1007/s10549-014-2892-z"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtho.2015.09.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008225023"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/djr325", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009817984"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jpainsymman.2005.07.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014042399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdt241", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014079863"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-009-0387-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014719185", 
          "https://doi.org/10.1007/s10549-009-0387-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-009-0387-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014719185", 
          "https://doi.org/10.1007/s10549-009-0387-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s10549-009-0387-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014719185", 
          "https://doi.org/10.1007/s10549-009-0387-0"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/caac.21387", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014894112"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jpainsymman.2003.04.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031659541"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/88.17.1210", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035451877"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(14)71207-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035529456"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2014.59.2360", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036725399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pon.1583", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038078417"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/pon.1583", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038078417"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2009.26.2543", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039864167"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.radonc.2014.07.014", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039989438"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-008-0558-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041995426", 
          "https://doi.org/10.1007/s00520-008-0558-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00520-008-0558-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041995426", 
          "https://doi.org/10.1007/s00520-008-0558-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/jto.0b013e31820eed00", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052957642"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jpainsymman.2010.01.017", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053471750"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077995313", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/caac.21390", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083396872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2017.7156", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1085885853"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4329/wjr.v9.i6.269", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1090169059"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1709937", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1091511599"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtho.2017.11.135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100242679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtho.2017.11.135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100242679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtho.2017.11.135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100242679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtho.2017.11.135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100242679"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jtho.2017.11.135", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100242679"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-03", 
    "datePublishedReg": "2019-03-01", 
    "description": "This study examined real-world clinical outcomes such as progression-free survival (PFS), time to metastasis (TTM), overall survival (OS), and health-related quality of life (HRQOL) in patients with unresected stage III non-small cell lung cancer (NSCLC) treated in the community setting. A retrospective review of medical records extracted from 10 US community oncology practices was conducted. Eligible patients were adults diagnosed with stage III NSCLC from 1/1/2011 to 3/1/2016 without evidence of surgical resection within 6 months after stage III NSCLC diagnosis (index date). PFS, OS, and TTM were assessed from the index date, and were analyzed using Kaplan-Meier and Cox regression analyses. HRQOL was assessed for a subset of patients using a patient-reported measure, the 86-item Patient Care Monitor (PCM). Linear mixed models (LMM) were used to assess the impact of patient characteristics and change in PCM scores associated with progression. Among the sample of 478 patients, median PFS (95% confidence interval) was 10 months (9-11), median OS was 20 months (17-22), and median TTM was 30 months (23-45). Most patients (58.2%) experienced disease progression, which the LMM showed to be associated with significant worsening of physical symptoms and psychological states (p\u2009<\u20090.001). This study documented PFS and OS consistent with published literature. The majority of patients experienced disease progression, which was associated with worsening of HRQOL. These findings highlighted the need for better therapeutic options in patients with unresected stage III NSCLC with potential to improve patient outcomes and HRQOL.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12032-019-1249-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1094524", 
        "issn": [
          "1357-0560", 
          "1559-131X"
        ], 
        "name": "Medical Oncology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "3", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "36"
      }
    ], 
    "name": "Real-world outcomes in patients with unresected stage III non-small cell lung cancer", 
    "pagination": "24", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "e59129e874073c372339f64218f95443f39e401eacbc7a500f6e7f07ca9aec7a"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30706218"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9435512"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12032-019-1249-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1111831523"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12032-019-1249-1", 
      "https://app.dimensions.ai/details/publication/pub.1111831523"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T10:32", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000349_0000000349/records_113655_00000005.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs12032-019-1249-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12032-019-1249-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12032-019-1249-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12032-019-1249-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12032-019-1249-1'


 

This table displays all metadata directly associated to this object as RDF triples.

189 TRIPLES      21 PREDICATES      53 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12032-019-1249-1 schema:about anzsrc-for:11
2 anzsrc-for:1117
3 schema:author Nd27e421ba1c745d0a08c92c11a1b71b2
4 schema:citation sg:pub.10.1007/s00520-008-0558-2
5 sg:pub.10.1007/s10549-009-0387-0
6 sg:pub.10.1007/s10549-014-2892-z
7 sg:pub.10.1186/1477-7525-9-46
8 https://app.dimensions.ai/details/publication/pub.1077995313
9 https://doi.org/10.1001/jama.2017.7156
10 https://doi.org/10.1002/pon.1583
11 https://doi.org/10.1016/j.jpainsymman.2003.04.003
12 https://doi.org/10.1016/j.jpainsymman.2005.07.009
13 https://doi.org/10.1016/j.jpainsymman.2010.01.017
14 https://doi.org/10.1016/j.jtho.2015.09.009
15 https://doi.org/10.1016/j.jtho.2017.11.135
16 https://doi.org/10.1016/j.radonc.2014.07.014
17 https://doi.org/10.1016/s1470-2045(14)71207-0
18 https://doi.org/10.1056/nejmoa1709937
19 https://doi.org/10.1093/annonc/mdt241
20 https://doi.org/10.1093/jnci/88.17.1210
21 https://doi.org/10.1093/jnci/djr325
22 https://doi.org/10.1097/jto.0b013e31820eed00
23 https://doi.org/10.1200/jco.2009.26.2543
24 https://doi.org/10.1200/jco.2014.59.2360
25 https://doi.org/10.3322/caac.21387
26 https://doi.org/10.3322/caac.21390
27 https://doi.org/10.4329/wjr.v9.i6.269
28 schema:datePublished 2019-03
29 schema:datePublishedReg 2019-03-01
30 schema:description This study examined real-world clinical outcomes such as progression-free survival (PFS), time to metastasis (TTM), overall survival (OS), and health-related quality of life (HRQOL) in patients with unresected stage III non-small cell lung cancer (NSCLC) treated in the community setting. A retrospective review of medical records extracted from 10 US community oncology practices was conducted. Eligible patients were adults diagnosed with stage III NSCLC from 1/1/2011 to 3/1/2016 without evidence of surgical resection within 6 months after stage III NSCLC diagnosis (index date). PFS, OS, and TTM were assessed from the index date, and were analyzed using Kaplan-Meier and Cox regression analyses. HRQOL was assessed for a subset of patients using a patient-reported measure, the 86-item Patient Care Monitor (PCM). Linear mixed models (LMM) were used to assess the impact of patient characteristics and change in PCM scores associated with progression. Among the sample of 478 patients, median PFS (95% confidence interval) was 10 months (9-11), median OS was 20 months (17-22), and median TTM was 30 months (23-45). Most patients (58.2%) experienced disease progression, which the LMM showed to be associated with significant worsening of physical symptoms and psychological states (p < 0.001). This study documented PFS and OS consistent with published literature. The majority of patients experienced disease progression, which was associated with worsening of HRQOL. These findings highlighted the need for better therapeutic options in patients with unresected stage III NSCLC with potential to improve patient outcomes and HRQOL.
31 schema:genre research_article
32 schema:inLanguage en
33 schema:isAccessibleForFree false
34 schema:isPartOf Nb9775c829cca4616ab2dfd1c01d8a3b2
35 Nc2a2998494a14a06af57d300f39a901c
36 sg:journal.1094524
37 schema:name Real-world outcomes in patients with unresected stage III non-small cell lung cancer
38 schema:pagination 24
39 schema:productId N27e145464b65469e8728c04ddcf2b9b5
40 N467af595ce1e49c0a255390eff9ca8a5
41 N4f05e1e0727849fd946204c96c24ccd6
42 Nb0ea2584fde948e68ea7d58d9542bb0a
43 Nf154be8b93e6430182c00efe72a3ba84
44 schema:sameAs https://app.dimensions.ai/details/publication/pub.1111831523
45 https://doi.org/10.1007/s12032-019-1249-1
46 schema:sdDatePublished 2019-04-11T10:32
47 schema:sdLicense https://scigraph.springernature.com/explorer/license/
48 schema:sdPublisher N990df1e675054862aa187ed225fba09c
49 schema:url https://link.springer.com/10.1007%2Fs12032-019-1249-1
50 sgo:license sg:explorer/license/
51 sgo:sdDataset articles
52 rdf:type schema:ScholarlyArticle
53 N178fbce789824f339143f554e5b1f20e rdf:first Nfc681ce9c6404458a891f8874a76e872
54 rdf:rest N7aa12c1bbb5c4302a7c46ed77ca50bb6
55 N2252eddc19504cd99257a05771a7b1d4 rdf:first Ncc14f0f5acdf436db989a0df219cc9e5
56 rdf:rest N178fbce789824f339143f554e5b1f20e
57 N27e145464b65469e8728c04ddcf2b9b5 schema:name doi
58 schema:value 10.1007/s12032-019-1249-1
59 rdf:type schema:PropertyValue
60 N4105aac415b34441acc10a3bd896436b schema:affiliation https://www.grid.ac/institutes/grid.488536.4
61 schema:familyName VanderWalde
62 schema:givenName Noam A.
63 rdf:type schema:Person
64 N467af595ce1e49c0a255390eff9ca8a5 schema:name readcube_id
65 schema:value e59129e874073c372339f64218f95443f39e401eacbc7a500f6e7f07ca9aec7a
66 rdf:type schema:PropertyValue
67 N4a56b55a28ec456090cd00cb741ae78a schema:affiliation https://www.grid.ac/institutes/grid.476107.3
68 schema:familyName Skinner
69 schema:givenName Karen E.
70 rdf:type schema:Person
71 N4f05e1e0727849fd946204c96c24ccd6 schema:name dimensions_id
72 schema:value pub.1111831523
73 rdf:type schema:PropertyValue
74 N4fbd3b22a5c54a168a1c839e516f19b9 rdf:first N5d6d546c854440aa8ee827fd46d8c9c7
75 rdf:rest N2252eddc19504cd99257a05771a7b1d4
76 N51e4716838e140a28a50b92237ed66d1 rdf:first N4a56b55a28ec456090cd00cb741ae78a
77 rdf:rest N4fbd3b22a5c54a168a1c839e516f19b9
78 N5d6d546c854440aa8ee827fd46d8c9c7 schema:affiliation https://www.grid.ac/institutes/grid.418152.b
79 schema:familyName Fernandes
80 schema:givenName Ancilla W.
81 rdf:type schema:Person
82 N5e172bb0160f4c108636e5b0694a95bf schema:affiliation https://www.grid.ac/institutes/grid.418152.b
83 schema:familyName Ryan
84 schema:givenName Kellie J.
85 rdf:type schema:Person
86 N718eaffa96d649ff818c654f6dd7b4d6 schema:affiliation https://www.grid.ac/institutes/grid.476107.3
87 schema:familyName Walker
88 schema:givenName Mark S.
89 rdf:type schema:Person
90 N7aa12c1bbb5c4302a7c46ed77ca50bb6 rdf:first N718eaffa96d649ff818c654f6dd7b4d6
91 rdf:rest Nb30e3c5c178b4dd2bfc3eb372c8c16f1
92 N990df1e675054862aa187ed225fba09c schema:name Springer Nature - SN SciGraph project
93 rdf:type schema:Organization
94 Nb0ea2584fde948e68ea7d58d9542bb0a schema:name pubmed_id
95 schema:value 30706218
96 rdf:type schema:PropertyValue
97 Nb30e3c5c178b4dd2bfc3eb372c8c16f1 rdf:first N4105aac415b34441acc10a3bd896436b
98 rdf:rest rdf:nil
99 Nb9775c829cca4616ab2dfd1c01d8a3b2 schema:volumeNumber 36
100 rdf:type schema:PublicationVolume
101 Nc2a2998494a14a06af57d300f39a901c schema:issueNumber 3
102 rdf:type schema:PublicationIssue
103 Ncc14f0f5acdf436db989a0df219cc9e5 schema:affiliation https://www.grid.ac/institutes/grid.417555.7
104 schema:familyName Punekar
105 schema:givenName Rajeshwari S.
106 rdf:type schema:Person
107 Nd27e421ba1c745d0a08c92c11a1b71b2 rdf:first N5e172bb0160f4c108636e5b0694a95bf
108 rdf:rest N51e4716838e140a28a50b92237ed66d1
109 Nf154be8b93e6430182c00efe72a3ba84 schema:name nlm_unique_id
110 schema:value 9435512
111 rdf:type schema:PropertyValue
112 Nfc681ce9c6404458a891f8874a76e872 schema:affiliation https://www.grid.ac/institutes/grid.418152.b
113 schema:familyName Pavilack
114 schema:givenName Melissa
115 rdf:type schema:Person
116 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
117 schema:name Medical and Health Sciences
118 rdf:type schema:DefinedTerm
119 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
120 schema:name Public Health and Health Services
121 rdf:type schema:DefinedTerm
122 sg:journal.1094524 schema:issn 1357-0560
123 1559-131X
124 schema:name Medical Oncology
125 rdf:type schema:Periodical
126 sg:pub.10.1007/s00520-008-0558-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041995426
127 https://doi.org/10.1007/s00520-008-0558-2
128 rdf:type schema:CreativeWork
129 sg:pub.10.1007/s10549-009-0387-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014719185
130 https://doi.org/10.1007/s10549-009-0387-0
131 rdf:type schema:CreativeWork
132 sg:pub.10.1007/s10549-014-2892-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1007214743
133 https://doi.org/10.1007/s10549-014-2892-z
134 rdf:type schema:CreativeWork
135 sg:pub.10.1186/1477-7525-9-46 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004761947
136 https://doi.org/10.1186/1477-7525-9-46
137 rdf:type schema:CreativeWork
138 https://app.dimensions.ai/details/publication/pub.1077995313 schema:CreativeWork
139 https://doi.org/10.1001/jama.2017.7156 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085885853
140 rdf:type schema:CreativeWork
141 https://doi.org/10.1002/pon.1583 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038078417
142 rdf:type schema:CreativeWork
143 https://doi.org/10.1016/j.jpainsymman.2003.04.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031659541
144 rdf:type schema:CreativeWork
145 https://doi.org/10.1016/j.jpainsymman.2005.07.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014042399
146 rdf:type schema:CreativeWork
147 https://doi.org/10.1016/j.jpainsymman.2010.01.017 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053471750
148 rdf:type schema:CreativeWork
149 https://doi.org/10.1016/j.jtho.2015.09.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008225023
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1016/j.jtho.2017.11.135 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100242679
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1016/j.radonc.2014.07.014 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039989438
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/s1470-2045(14)71207-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035529456
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1056/nejmoa1709937 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091511599
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1093/annonc/mdt241 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014079863
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1093/jnci/88.17.1210 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035451877
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1093/jnci/djr325 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009817984
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1097/jto.0b013e31820eed00 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052957642
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1200/jco.2009.26.2543 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039864167
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1200/jco.2014.59.2360 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036725399
170 rdf:type schema:CreativeWork
171 https://doi.org/10.3322/caac.21387 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014894112
172 rdf:type schema:CreativeWork
173 https://doi.org/10.3322/caac.21390 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083396872
174 rdf:type schema:CreativeWork
175 https://doi.org/10.4329/wjr.v9.i6.269 schema:sameAs https://app.dimensions.ai/details/publication/pub.1090169059
176 rdf:type schema:CreativeWork
177 https://www.grid.ac/institutes/grid.417555.7 schema:alternateName Sanofi (United States)
178 schema:name Sanofi, 50 Binney Street, 2nd floor, 02142, Cambridge, MA, USA
179 Vector Oncology, 6555 Quince, Suite 400, 38119, Memphis, TN, USA
180 rdf:type schema:Organization
181 https://www.grid.ac/institutes/grid.418152.b schema:alternateName AstraZeneca (United States)
182 schema:name AstraZeneca, One MedImmune Way, 20878, Gaithersburg, MD, USA
183 rdf:type schema:Organization
184 https://www.grid.ac/institutes/grid.476107.3 schema:alternateName Vector Oncology (United States)
185 schema:name Vector Oncology, 6555 Quince, Suite 400, 38119, Memphis, TN, USA
186 rdf:type schema:Organization
187 https://www.grid.ac/institutes/grid.488536.4 schema:alternateName West Cancer Center
188 schema:name West Cancer Center, 7945 Wolf River Boulevard, 38138, Germantown, TN, USA
189 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...